New Age Ventures

Opterion Health is dedicated to advancing dialysis care, particularly through home dialysis solutions, to enhance the quality of life for patients with end-stage renal disease (ESRD) and chronic kidney disease. The company offers both hemodialysis and peritoneal dialysis options, aiming to improve patient outcomes and potentially increase survival rates. By fostering innovative approaches to dialysis, Opterion Health seeks to alleviate the challenges faced by patients and their families, while also assisting healthcare institutions in managing related health issues, such as insulin dosage and glucose management.

Goodhood operates a subscription-based auto repair platform that provides convenient car maintenance services directly to customers' doorsteps. By connecting car owners with skilled mechanics, Goodhood allows users to browse, book, and manage their service appointments through an easy-to-use platform. This innovative approach enables customers to access highly-rated mobile car repair services at their convenience, making car maintenance more accessible and efficient.

Koios Medical, Inc. is a Chicago-based company that develops an ultrasound image analysis platform aimed at enhancing early disease detection and diagnosis. Founded in 2011, the company utilizes artificial intelligence and machine learning to create algorithms that serve as a decision support system. This platform is trained on extensive datasets, including hundreds of thousands of images and associated pathology results, enabling healthcare institutions to improve the accuracy of cancer detection and diagnosis. Koios Medical's focus is on delivering software medical device products that comply with customer and regulatory standards, ultimately enhancing clinical decision-making and the overall quality of care in the healthcare sector.

Goodhood operates a subscription-based auto repair platform that provides convenient car maintenance services directly to customers' doorsteps. By connecting car owners with skilled mechanics, Goodhood allows users to browse, book, and manage their service appointments through an easy-to-use platform. This innovative approach enables customers to access highly-rated mobile car repair services at their convenience, making car maintenance more accessible and efficient.

Tabella is a developer of a social networking software application tailored for Catholic communities, providing a free, private, and secure platform for users to engage digitally. The application facilitates communication among faith communities, allowing members to stay connected and deepen their religious practices. It offers subscription content that supports spiritual growth and enables churches to collect donations, fostering enhanced community engagement. Through its platform, Tabella aims to strengthen the bonds between individuals and their faith, promoting a sense of closeness to both their community and God.

Telescope Innovations is a chemical manufacturing company that operates as a Contract Research Organization (CRO). It specializes in providing contract research services and developing automation products. The company generates revenue through two main streams: offering contract research services and selling its automation products. In addition to these services, Telescope Innovations is also involved in intellectual property development and licensing, positioning itself as a versatile entity within the technology and chemical sectors.

FEMSelect Inc. specializes in designing and developing surgical systems and devices for pelvic floor ligament fixation, focusing on women's health. The company is known for its innovative EnPlace system, a minimally invasive and mesh-free solution for treating pelvic organ prolapse (POP). This patented technology allows for precise guidance and deployment of an anchor unit that stabilizes the pelvic floor ligament through a vaginal approach, significantly enhancing patient recovery and comfort. The procedure typically takes about 30 minutes and does not require overnight hospital stays or result in visible scarring. Founded in 2012, FEMSelect operates from its headquarters in Newark, Delaware.

Spruce develops a platform that enables individuals to receive services in their homes through a mobile app. Its services range from full housekeeping to a quick tidy up or a dog walk for a furry friend. The company was founded in 2016 and is headquartered in Austin, Texas.

NewIV Medical develops an innovative infusion pump designed to enhance intravenous therapy while reducing healthcare costs. The company's flagship product, a breeze pneumatic infusion pump, incorporates various advancements to meet essential clinical and patient requirements in the home infusion market. By focusing on improving the quality of therapy, NewIV Medical aims to support healthcare providers in delivering effective care at a lower expense.

Aqualung specializes in carbon capture technology aimed at helping industries manage their emission challenges. The company offers compact carbon capture systems for industrial flue gas and biogas, utilizing advanced membrane technology that provides an environmentally friendly and cost-effective solution. By employing a second-generation membrane process, Aqualung delivers services that not only minimize the physical footprint of carbon capture systems but also enhance the efficiency of CO2 removal. This innovative approach significantly contributes to decarbonization efforts, allowing industries to reduce their carbon emissions in a sustainable manner.

Spruce develops a platform that enables individuals to receive services in their homes through a mobile app. Its services range from full housekeeping to a quick tidy up or a dog walk for a furry friend. The company was founded in 2016 and is headquartered in Austin, Texas.

Tilting Point, established in 2012, operates as a marketing and publishing platform dedicated to scaling and supporting live games. With a workforce of over 130 employees across offices in New York, Boston, Barcelona, Kiev, and Seoul, the company collaborates with development studios and publishers in various countries. It has achieved notable success with games such as Star Trek Timelines, Warhammer: Chaos & Conquest, and SpongeBob: Krusty Cook-Off, the latter reaching the top 10 in 97 countries upon its launch. Tilting Point employs a data-driven approach to game development and user acquisition, allowing independent developers to focus on creativity while minimizing investment risks. The company aims to foster long-term partnerships with developers, enhancing their existing games and exploring new collaborative projects.

Li-FT Power is a mineral exploration company dedicated to the identification, acquisition, and exploration of early-stage lithium pegmatite projects in Canada. The company has a diverse portfolio that includes several key projects: the Rupert Project, a significant 155,000-hectare greenfield exploration site, along with the Pontax Project, Moyenne Project, and Lithium Yellowknife Project. Through its focus on lithium, Li-FT Power aims to advance its exploration efforts to contribute to the growing demand for this crucial mineral.

Artract Medical hemodynamic assist device for the treatment of the heart. The Attract System is a passive hemodynamic assist device that is implanted percutaneously for the treatment of heart failure with preserved ejection fraction. Artract reduces left atrial blood pressure, easing shortness of breath.

MetaSoul, based in New York and established in 2017, specializes in advanced emotion synthesis technology for artificial intelligence applications. The company focuses on creating emotional awareness in AI, enabling machines to generate and understand a range of emotional states through multimodal stimuli. MetaSoul's flagship product, the Emotional Processing Unit (EPU), allows AI systems to respond to user interactions with emotional intelligence, enhancing applications in diverse fields such as gaming, healthcare, and the metaverse. The technology is capable of controlling both vocal expressions and facial micro-expressions in digital entities, providing a more lifelike interaction experience. MetaSoul holds foundational patents for its innovative approach to emotion synthesis, which not only detects but also shapes emotional responses in machines. By utilizing reinforcement learning and a unique Emotion Profile Graph, the technology allows for the development of distinct emotional personalities in AI, creating a personalized user experience. As generative AI continues to evolve, MetaSoul positions itself as a leader in integrating emotional intelligence into digital interactions, paving the way for more meaningful engagements between humans and machines.

Tabella is a developer of a social networking software application tailored for Catholic communities, providing a free, private, and secure platform for users to engage digitally. The application facilitates communication among faith communities, allowing members to stay connected and deepen their religious practices. It offers subscription content that supports spiritual growth and enables churches to collect donations, fostering enhanced community engagement. Through its platform, Tabella aims to strengthen the bonds between individuals and their faith, promoting a sense of closeness to both their community and God.

BrainCheck, Inc. specializes in cognitive health solutions for healthcare and athletic organizations in the United States, focusing on assessment and monitoring of cognitive health. The company offers a mobile application compatible with iOS and Android devices that provides tools for individuals to evaluate their cognitive health, particularly concerning issues like concussions and memory changes. This application facilitates the connection between patients and care teams in the concussion and dementia sectors. Users can access interactive tests and screening tools via any mobile device or web browser, allowing for immediate assessment of brain health. Clinicians can track significant changes in cognitive health and share results with patients, thereby enhancing decision-making regarding cognitive health concerns. Founded in 2013, BrainCheck is headquartered in Houston, Texas.

MetaSoul, based in New York and established in 2017, specializes in advanced emotion synthesis technology for artificial intelligence applications. The company focuses on creating emotional awareness in AI, enabling machines to generate and understand a range of emotional states through multimodal stimuli. MetaSoul's flagship product, the Emotional Processing Unit (EPU), allows AI systems to respond to user interactions with emotional intelligence, enhancing applications in diverse fields such as gaming, healthcare, and the metaverse. The technology is capable of controlling both vocal expressions and facial micro-expressions in digital entities, providing a more lifelike interaction experience. MetaSoul holds foundational patents for its innovative approach to emotion synthesis, which not only detects but also shapes emotional responses in machines. By utilizing reinforcement learning and a unique Emotion Profile Graph, the technology allows for the development of distinct emotional personalities in AI, creating a personalized user experience. As generative AI continues to evolve, MetaSoul positions itself as a leader in integrating emotional intelligence into digital interactions, paving the way for more meaningful engagements between humans and machines.

The Arcview Group, LLC is an investment and research company focused on the cannabis industry, established in 2010 and based in San Francisco, California. The firm connects investors with cannabis-related businesses, helping entrepreneurs secure funding through its network of investor members. It provides support across various sectors, including LED lighting technology, inventory management, compliance, property investment, organic nutrients, hemp cultivation, CBD extraction, and cannabis packaging. The Arcview Group also assists licensed cultivators, retailers, and infused product manufacturers in navigating the evolving legal cannabis landscape. In addition to facilitating investments, the company hosts webinars and develops tools like the MyDispensary Mobile App to further support the industry. Through initiatives such as The Arcview Angel Network, the organization aims to foster the growth of the next generation of cannabis enterprises.

Venock Inc. is a MedTech startup based in New York City with operations in Munich, Germany, focused on developing innovative vascular closure devices for large bore access sites exceeding 8 mm, primarily in venous applications. Established in 2018, the company addresses a significant unmet need in the industry, targeting a market valued over $2 billion. Venock's device significantly improves closure time, achieving full vascular closure within one minute compared to traditional manual compression methods, which are time-consuming and uncomfortable for patients. The handheld, fully percutaneous system enhances efficiency for healthcare professionals by enabling rapid cessation of venous bleeding, thereby reducing hospital resource drain and improving patient turnover during interventional transcatheter therapies. While currently focused on venous closure, the underlying technology is applicable to both veins and arteries.

Neosensory, Inc. is a company that specializes in developing wearable devices aimed at enhancing sensory perception for individuals. Founded in 2015 and based in San Mateo, California, Neosensory offers products such as Buzz, which utilizes vision-to-touch sensory substitution technology to assist blind individuals. The company focuses on transmitting various data streams to the brain through the sense of touch, leveraging the skin's potential for information delivery. Their innovative approach includes building hearing assistive technology that allows users to perceive sound through vibrations on the skin. Neosensory also provides a companion application for its products, enhancing the user experience and accessibility of information.

MetaSoul, based in New York and established in 2017, specializes in advanced emotion synthesis technology for artificial intelligence applications. The company focuses on creating emotional awareness in AI, enabling machines to generate and understand a range of emotional states through multimodal stimuli. MetaSoul's flagship product, the Emotional Processing Unit (EPU), allows AI systems to respond to user interactions with emotional intelligence, enhancing applications in diverse fields such as gaming, healthcare, and the metaverse. The technology is capable of controlling both vocal expressions and facial micro-expressions in digital entities, providing a more lifelike interaction experience. MetaSoul holds foundational patents for its innovative approach to emotion synthesis, which not only detects but also shapes emotional responses in machines. By utilizing reinforcement learning and a unique Emotion Profile Graph, the technology allows for the development of distinct emotional personalities in AI, creating a personalized user experience. As generative AI continues to evolve, MetaSoul positions itself as a leader in integrating emotional intelligence into digital interactions, paving the way for more meaningful engagements between humans and machines.

High North Laboratories is a cannabis-specific company focused on providing quality testing and GMP compliance for the cannabis industry. Built on a digital infrastructure, the laboratory aims to deliver faster and more reliable results to cannabis growers and producers. By ensuring transparency in product testing, High North Laboratories helps customers access quality cannabis products, thereby setting a standard for testing within the sector.

Annex specializes in the design and manufacture of innovative smoking instruments that aim to minimize the smoke and odor associated with smoking. The company has developed a comprehensive smoking kit equipped with features such as a long-lasting battery, an auto extinguishing system, and a removable mouthpiece for sanitation purposes. Additionally, the kit incorporates a filter track system made from eco-friendly plastics derived from cannabis waste. This product is intended to address the adverse effects of secondhand smoke, offering a more considerate experience for cannabis smokers and those in their vicinity.

MetaSoul, based in New York and established in 2017, specializes in advanced emotion synthesis technology for artificial intelligence applications. The company focuses on creating emotional awareness in AI, enabling machines to generate and understand a range of emotional states through multimodal stimuli. MetaSoul's flagship product, the Emotional Processing Unit (EPU), allows AI systems to respond to user interactions with emotional intelligence, enhancing applications in diverse fields such as gaming, healthcare, and the metaverse. The technology is capable of controlling both vocal expressions and facial micro-expressions in digital entities, providing a more lifelike interaction experience. MetaSoul holds foundational patents for its innovative approach to emotion synthesis, which not only detects but also shapes emotional responses in machines. By utilizing reinforcement learning and a unique Emotion Profile Graph, the technology allows for the development of distinct emotional personalities in AI, creating a personalized user experience. As generative AI continues to evolve, MetaSoul positions itself as a leader in integrating emotional intelligence into digital interactions, paving the way for more meaningful engagements between humans and machines.

OrthogenRx is a commercial-stage product development company focused on orthopedic medical devices aimed at treating musculoskeletal conditions, particularly knee joint pain. The company's primary product is an injection designed to lubricate the knee joint and alleviate mild to moderate pain for patients who have not adequately responded to conservative treatments. OrthogenRx employs a business model that leverages exclusive supply and license agreements for products available outside the United States, while also pursuing generic product approval domestically. This approach aims to reduce healthcare costs significantly by utilizing existing regulations for abbreviated approval of generic devices, similar to the process for generic drugs. By providing safe and effective non-surgical alternatives, OrthogenRx addresses the needs of patients seeking relief from joint pain.

OrthogenRx is a commercial-stage product development company focused on orthopedic medical devices aimed at treating musculoskeletal conditions, particularly knee joint pain. The company's primary product is an injection designed to lubricate the knee joint and alleviate mild to moderate pain for patients who have not adequately responded to conservative treatments. OrthogenRx employs a business model that leverages exclusive supply and license agreements for products available outside the United States, while also pursuing generic product approval domestically. This approach aims to reduce healthcare costs significantly by utilizing existing regulations for abbreviated approval of generic devices, similar to the process for generic drugs. By providing safe and effective non-surgical alternatives, OrthogenRx addresses the needs of patients seeking relief from joint pain.

OrthogenRx is a commercial-stage product development company focused on orthopedic medical devices aimed at treating musculoskeletal conditions, particularly knee joint pain. The company's primary product is an injection designed to lubricate the knee joint and alleviate mild to moderate pain for patients who have not adequately responded to conservative treatments. OrthogenRx employs a business model that leverages exclusive supply and license agreements for products available outside the United States, while also pursuing generic product approval domestically. This approach aims to reduce healthcare costs significantly by utilizing existing regulations for abbreviated approval of generic devices, similar to the process for generic drugs. By providing safe and effective non-surgical alternatives, OrthogenRx addresses the needs of patients seeking relief from joint pain.

BootstrapLabs, established in 2008, is a Silicon Valley-based venture capital firm specializing in early-stage investments, with a focus on Applied Artificial Intelligence. The firm invests in sectors such as The Future of Work, Mobility, Health, Financial Infrastructure, Digital Infrastructure, Energy/Climate, and AI-enabling technologies. BootstrapLabs often acts as the first institutional investor and provides follow-on capital at growth stages. It offers two accelerator programs - a Global Accelerator Program in Silicon Valley and a Local Accelerator Program in Southeast Asia - to support foreign-born startups navigating American markets. The firm typically invests up to $0.1 million, offers monthly onboarding, and selects companies with at least two people who can code and build UX with a few users. BootstrapLabs is committed to supporting founders through challenges and setbacks, fostering a nurturing community, and using technology to create a positive impact on society.

OrthogenRx is a commercial-stage product development company focused on orthopedic medical devices aimed at treating musculoskeletal conditions, particularly knee joint pain. The company's primary product is an injection designed to lubricate the knee joint and alleviate mild to moderate pain for patients who have not adequately responded to conservative treatments. OrthogenRx employs a business model that leverages exclusive supply and license agreements for products available outside the United States, while also pursuing generic product approval domestically. This approach aims to reduce healthcare costs significantly by utilizing existing regulations for abbreviated approval of generic devices, similar to the process for generic drugs. By providing safe and effective non-surgical alternatives, OrthogenRx addresses the needs of patients seeking relief from joint pain.

TRANSCATHETER TECHNOLOGIES is developing a unique aortic valve implantation system that will increase the safety and durability of aortic valve implantation. The TRINITY repositionable transcatheter aortic valve system is at the forefront of next-generation transcatheter valve implantation technology. In the near future, transcatheter valve implantation will become the preferred therapy for aortic valve implantation, and TRANSCATHETER TECHNOLOGIES‘ goal is to provide the most advanced technology available.

TRANSCATHETER TECHNOLOGIES is developing a unique aortic valve implantation system that will increase the safety and durability of aortic valve implantation. The TRINITY repositionable transcatheter aortic valve system is at the forefront of next-generation transcatheter valve implantation technology. In the near future, transcatheter valve implantation will become the preferred therapy for aortic valve implantation, and TRANSCATHETER TECHNOLOGIES‘ goal is to provide the most advanced technology available.

FEMSelect Inc. specializes in designing and developing surgical systems and devices for pelvic floor ligament fixation, focusing on women's health. The company is known for its innovative EnPlace system, a minimally invasive and mesh-free solution for treating pelvic organ prolapse (POP). This patented technology allows for precise guidance and deployment of an anchor unit that stabilizes the pelvic floor ligament through a vaginal approach, significantly enhancing patient recovery and comfort. The procedure typically takes about 30 minutes and does not require overnight hospital stays or result in visible scarring. Founded in 2012, FEMSelect operates from its headquarters in Newark, Delaware.